Hypertension Trial, Recruiting (NCT06340152)

Hypertension Trial, Recruiting NCT06340152 Sponsor: University of California, San Diego Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06340152 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Pregnant women between 18 and 50 years of age
Between 10 and 24 weeks pregnant at the time of joining the trial
Carrying a single baby (not twins or more)
Planning to give birth at one of the two study hospitals (UC San Diego or Vanderbilt University Medical Center)

Who may not be able to join:

People who are unable to provide informed consent to participate
Pregnancies where the baby has passed away in the womb
Pregnancies where the baby has a known genetic condition or physical abnormality
People who are currently in a psychiatric institution, have been assessed as having a significant mental deficiency, or are incarcerated
People with an active cancer diagnosis or a history of cancer that required major surgery or treatment given throughout the body (such as chemotherapy)
Pregnancies with more than one baby, or pregnancies that started as twins where one baby did not survive at any point
Cases where a known chromosomal abnormality has been identified in either the mother or the baby
People who plan to keep their placenta after giving birth

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Louise Laurent, MD, PhD, UCSD

Phone: 858-249-5985

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06340152

Sponsor: University of California, San Diego

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 858-249-5985

More information: https://clinicaltrials.gov/study/NCT06340152

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Pregnant women between 18 and 50 years of age
Between 10 and 24 weeks pregnant at the time of joining the trial
Carrying a single baby (not twins or more)
Planning to give birth at one of the two study hospitals (UC San Diego or Vanderbilt University Medical Center)

Who may not be able to join:

People who are unable to provide informed consent to participate
Pregnancies where the baby has passed away in the womb
Pregnancies where the baby has a known genetic condition or physical abnormality
People who are currently in a psychiatric institution, have been assessed as having a significant mental deficiency, or are incarcerated
People with an active cancer diagnosis or a history of cancer that required major surgery or treatment given throughout the body (such as chemotherapy)
Pregnancies with more than one baby, or pregnancies that started as twins where one baby did not survive at any point
Cases where a known chromosomal abnormality has been identified in either the mother or the baby
People who plan to keep their placenta after giving birth

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Diego

Registry

ClinicalTrials.gov

Start date

20 December 2023

Est. completion

1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Preeclampsia; Gestational hypertension; Postpartum hypertension

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov